Urachal Adenocarcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-07-28
Clinical Trial Update: Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology [Phase 2]
Phase 2 study evaluating Enfortumab Vedotin plus Pembrolizumab for locally advanced or metastatic bladder cancer with variant histology. The…